Does resperidone cause respiratory manifestations?;La risperidone est-elle responsable de manifestations respiratoires?

Revue des Maladies Respiratoires

Volumn 17, Issue 1, 2000, Pages 117-118

  Touraine, F ^a   Clavel, M ^a   Gericot Pean, E ^a   Antonini, M Th ^b   Nouaille, Y ^b   Ratti, A ^c   Lombertie, E R ^c   Bonnaud, F ^a  

^a Hopital du Cluzeau   (France)

^b LIMOGES UNIVERSITY HOSPITAL   (France)

^c Service de Psychiatrie   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE; BROMOCRIPTINE; CETIRIZINE; HYDROXYZINE; METHYLPREDNISOLONE; PAROXETINE; RISPERIDONE; SALMETEROL; NEUROLEPTIC AGENT;

ADULT; ARTICLE; BRONCHOSPASM; CLINICAL EXAMINATION; CORTICOSTEROID THERAPY; DEPRESSION; DRUG SAFETY; FEMALE; HUMAN; PERSONALITY DISORDER; BREATHING DISORDER; CASE REPORT; CHEMICALLY INDUCED DISORDER; COUGHING; DRUG HYPERSENSITIVITY; DYSPNEA;

ADULT; ANTIPSYCHOTIC AGENTS; COUGH; DRUG HYPERSENSITIVITY; DYSPNEA; FEMALE; HUMANS; RESPIRATION DISORDERS; RISPERIDONE;

EID: 0034013335     PISSN: 07618425     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. FOUCHER P, RIOUR M, BLAYAK JP, GODARD F, SGRO C, KUHN M, VERGNON JM, VERVLOET D, PFITZENMEYER P, OLLAGNIER M, MAYAUD Ch, CAMUS Ph : Drugs that may injure the respiratory system. Eur Respir J 1997;10:265-79.
2. CAMUS P : Pathologie pulmonaire médicamenteuse 1. Le Concours Médical 1994;116:591-602.
3. CAMUS P : Pathologie pulmonaire médicamenteuse 2. Le Concours Médical 1994;116:701-6.
4. CAMUS P : Pathologie pulmonaire médicamenteuse 3. Le Concours Médical 1994;116:785-90.
5. SPADONE Ch, OLIE JP : Schizophrénie : aspects thérapeutiques. Médecine Thérapeutique 1996;vol.2 n°8:621-6.
6. TERAO T, KOJIMA H, ETO A : Risperidone and allergic reactions. J Clin Psychiatry 1998:59(2) :82-3.
7. GRANT S, FITTON A : Risperidone. A review of its pharmacology and therapeutic potential in the treatment of schizophrenie. Drug 1994;48(2) :253-73.
8. AKOUN G : Les critères diagnostiques du poumon médicamenteux. Journées Parisiennes d'Allergologie 1995:176-7.
9. MAYAUD Ch, DE GROOTE E, PARROT A, HOUACINE S, DENIS M, AKOUN G : Les pneumopathies médicamenteuses aiguës hypoxémiantes non liées aux cytotoxiques. Rev Pneumol Clin 1993;49:120-128.
10. VERVLOET D, PRADAL M : Diagnostic de l'allergie médicamenteuse. Journées Parisiennes d'Allergie 1995:187-95.
11. IMBS JL, WELSCH M : La toux aux inhibiteurs de l'enzyme de conversion. J Med Strasbourg 1989;20:39-40.
12. LUNDE H, HEDNER T, SAMUELSON O, LOTWALL J, ANDREN L, LINDHOLN L, WIHOEM B : Dyspnoea, asthma and bronchospasme in relation to treatment with angiotensin convening enzyme inhibitors. BMJ 1994;308:18-21.
13. SONG F : Risperidone in the treatment of schizophrenia : a meta analysis of randomized controlled trials. Journal of psychopharmacology 1997;11:65-71.
14. COONEY C, NAGY A : Angio-oedema associated with risperidone. BMJ 1995;310:1204.